COVID-19 mortality: are comorbidities, socio-economic status and ethnicity more important than cancer?

By FYH News Team

Published on January 20, 2023

[ad_1]

Editorial

doi: 10.21037/atm-22-5592.

Affiliations

¹ Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.
² Université Paris-Est Créteil, INSERM, IMRB, Créteil, France.
³ AP-HP, Henri-Mondor Hospital, Public Health Department & Clinical Research Unit (URC Mondor), Créteil, France.
⁴ INSERM U938, CRSA, Institut Universitaire de Cancérologie, AP-HP Sorbonne Université, Paris, France.

Item in Clipboard

Editorial

Lauren Seknazi et al.

Ann Transl Med.

2022 Dec.

doi: 10.21037/atm-22-5592.

Affiliations

¹ Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.
² Université Paris-Est Créteil, INSERM, IMRB, Créteil, France.
³ AP-HP, Henri-Mondor Hospital, Public Health Department & Clinical Research Unit (URC Mondor), Créteil, France.
⁴ INSERM U938, CRSA, Institut Universitaire de Cancérologie, AP-HP Sorbonne Université, Paris, France.

Item in Clipboard

No abstract available

Keywords:

Coronavirus disease 2019 (COVID-19); comorbidities; ethnicity.

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-5592/coif). The authors have no conflicts of interest to declare.

Comment on

Mortality and prognostic factors in hospitalized COVID-19 patients with cancer: an analysis from a large healthcare system in the United States.

Raez LE, Tarockoff M, Carracedo Uribe CR, Niu J, Sareli C, Sundararaman N, Ion J, Eckardt P, Alvarez-Pinzon A, Hussein A.
Raez LE, et al.
Ann Transl Med. 2022 Oct;10(20):1090. doi: 10.21037/atm-22-1667.
Ann Transl Med. 2022.

PMID: 36388785
Free PMC article.

[ad_2]

Source link

Features

Download and distribute powerful vaccination QI resources for your community.

MCED tests use a simple blood draw to screen for many kinds of cancer at once.

FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.

Discover an honest look at our Medicare system.

ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.